March 17, 2025 — Bayer recently announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental new ...
March 17, 2025 – Ostial Corp., a privately held medical technology company focused on addressing the clinical challenges ...
March 17, 2025 — Being born with a heart defect may be associated with an increased cancer risk for babies and their ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
March 17, 2025 — GE HealthCare recently launched the AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab. The AltiX AI ...
SCAI Scientific Sessions 2025 will take place May 1 to 3, at the Walter E. Washington Convention Center in Washington ...
March 11, 2025 — CareDx, Inc. – The Transplant Company – recently announced that AlloSure is now commercially available ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial ...
March 12, 2025 – New research from Karl Landsteiner University of Health Sciences (KL Krems) in Austria provides ...
Mar. 10, 2025-- Corcept Therapeutics Inc., a commercial-stage company engaged in the discovery and development of ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
March 11, 2025 — The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular ...
March 11, 2025 — Caristo Diagnostics has received U.S. Food and Drug Administration (FDA) 510(k) clearance of its CaRi ...
At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., Medtronic presented new data and ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Feb. 22, 2025 — More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the ...
March 3, 2025 — Genentech, a member of the Roche Group, recently announced that the U.S. Food and Drug Administration ...
March 1, 202 — One in three people worldwide will develop a potentially life-threatening heart rhythm disorder in their ...